A Phase 1, Open-Label, Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH) Risperidone When Risperidone is Administered From a Polyurethane Implant
Phase of Trial: Phase I
Latest Information Update: 04 Nov 2014
At a glance
- Drugs Risperidone (Primary)
- Indications Schizophrenia
- Focus Pharmacokinetics
- Sponsors Endo Pharmaceuticals
- 02 Nov 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Sep 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 31 Jan 2013 New trial record